Swift Implementation of Tailored Enterprise Software Solutions
Company Size
1,000+
Region
- Europe
Country
- Germany
Product
- Genedata Expressionist
Tech Stack
- Mass Spectrometry
- Data Analysis
Implementation Scale
- Enterprise-wide Deployment
Impact Metrics
- Innovation Output
- Productivity Improvements
Technology Category
- Analytics & Modeling - Data-as-a-Service
- Analytics & Modeling - Real Time Analytics
Applicable Industries
- Pharmaceuticals
Applicable Functions
- Product Research & Development
- Quality Assurance
Use Cases
- Predictive Quality Analytics
- Root Cause Analysis & Diagnosis
Services
- Data Science Services
- System Integration
About The Customer
Bayer Pharmaceuticals is a company that focuses on researching, developing, manufacturing and supplying specialty-focused innovative medicines that provide significant clinical benefit and value. The company has been a customer since 2006. Comprehensive characterization and efficient quality monitoring are key factors to ensure safety and efficacy of novel biotherapeutics while reducing their development costs. Providing information at the molecular-level and delivering high analytical throughput, mass spectrometry is increasingly being used across the biopharma industry to supplement and replace established analytical techniques that cannot address the inherent structural complexity of biotherapeutics. To keep pace with the increasing demand for MS-based analyses, Bayer expanded their lab’s capacity and capabilities by acquiring two new instruments and developing novel protocols for intact mass analysis and peptide mapping.
The Challenge
Bayer Pharmaceuticals was facing several challenges in their lab. They were developing new methods to characterize novel classes of biopharmaceuticals, which was compounded by the novel nature of the analytes, for which no established MS-based protocols were available. Interpreting results and iteratively optimizing experimental and analytical methods for such molecules required a significant amount of area expertise in MS-based characterization of biotherapeutics. They also needed to deliver productive output in a timely manner to meet the needs of their internal customers involved in time-critical projects and maximize Bayer’s return on investment in new infrastructure. The novel nature of their analytes and protocols and the limitations of the available software made interpretation of results far from straightforward. When troubleshooting a complex process issue, it was extremely helpful to have not only domain expertise, but also to have a comprehensive and unbiased overview of all data at all stages of processing. Any solution that they implemented had to be scalable and able to handle high sample throughputs. Using the available software, data processing and the production of targeted reports were laborious and time-consuming processes that required frequent manual interventions.
The Solution
Bayer Pharmaceuticals established a partnership with Genedata to overcome their challenges. Genedata began with their scientific consultants visiting Bayer's site and carrying out a comprehensive analysis of their entire MS data acquisition and processing workflow. Through careful consultation with Bayer's scientists, Genedata identified their current and future needs for an MS data processing platform. Working in close collaboration with Genedata experts, Bayer evaluated the results, designed an optimized end-to-end MS analysis strategy—from sample preparation to result reporting—and planned an implementation timeline that addressed and prioritized their needs. During the implementation phase, Genedata consultants provided extensive on-site training, regularly visited Bayer's site to monitor progress, and reacted very quickly to all their requests for support. After successfully applying the intact mass analysis workflow in their lab, Bayer was able to quickly develop and implement additional solutions for peptide mapping and oligonucleotide analysis, and they are currently developing more workflows.
Operational Impact
Case Study missing?
Start adding your own!
Register with your work email and create a new case study profile for your business.
Related Case Studies.
Case Study
Case Study: Pfizer
Pfizer’s high-performance computing software and systems for worldwide research and development support large-scale data analysis, research projects, clinical analytics, and modeling. Pfizer’s computing services are used across the spectrum of research and development efforts, from the deep biological understanding of disease to the design of safe, efficacious therapeutic agents.
Case Study
Fusion Middleware Integration on Cloud for Pharma Major
Customer wanted a real-time, seamless, cloud based integration between the existing on premise and cloud based application using SOA technology on Oracle Fusion Middleware Platform, a Contingent Worker Solution to collect, track, manage and report information for on-boarding, maintenance and off-boarding of contingent workers using a streamlined and Integrated business process, and streamlining of integration to the back-end systems and multiple SaaS applications.
Case Study
Process Control System Support
In many automated production facilities, changes are made to SIMATIC PCS 7 projects on a daily basis, with individual processes often optimised by multiple workers due to shift changes. Documentation is key here, as this keeps workers informed about why a change was made. Furthermore, SIMATIC PCS 7 installations are generally used in locations where documentation is required for audits and certification. The ability to track changes between two software projects is not only an invaluable aid during shift changes, but also when searching for errors or optimising a PCS 7 installation. Every change made to the system is labour-intensive and time-consuming. Moreover, there is also the risk that errors may occur. If a change is saved in the project, then the old version is lost unless a backup copy was created in advance. If no backup was created, it will no longer be possible to return to the previous state if and when programming errors occur. Each backup denotes a version used by the SIMATIC PCS 7 system to operate an installation. To correctly interpret a version, information is required on WHO changed WHAT, WHERE, WHEN and WHY: - Who created the version/who is responsible for the version? - Who released the version? - What was changed in the version i.e. in which block or module of the SIMATIC PCS 7 installation were the changes made? - When was the version created? Is this the latest version or is there a more recent version? - Why were the changes made to the version? If they are part of a regular maintenance cycle, then is the aim to fix an error or to improve production processes? - Is this particular version also the version currently being used in production? The fact that SIMATIC PCS 7 projects use extremely large quantities of data complicates the situation even further, and it can take a long time to load and save information as a result. Without a sustainable strategy for operating a SIMATIC PCS 7 installation, searching for the right software version can become extremely time-consuming and the installation may run inefficiently as a result.
Case Study
Drug Maker Takes the Right Prescription
China Pharm decided to build a cloud-based platform to support the requirements of IT planning for the next five to ten years which includes a dynamic and scalable mail resource pool platform. The platform needed to have the following functions: all nodes support redundancy, ensuring service continuity and good user experience, simple and easy-to-use user interfaces for end users and administrators and good compatibility and supports smooth capacity expansion.
Case Study
ELI LILLY ADOPTS MICROMEDIA’S ALERT NOTIFICATION SYSTEM
Pharmaceutical production is subject to a strict set of enforced rules that must be adhered to and compliance to these standards is critically necessary. Due to the efforts of WIN 911’s strategic partner Micromedia, Lilly was able to adopt an alarm notification infrastructure that integrated smoothly with their existing workflows and emergency hardware and protocols. These raw energy sources enable the industrial process to function: electricity, WIN-911 Software | 4020 South Industrial Drive, Suite 120 | Austin, TX 78744 USA industrial steam, iced water, air mixtures of varying quality. Refrigeration towers, boilers and wastewater are monitored by ALERT. Eli Lilly identified 15000 potential variables, but limitations compelled them to chisel the variable list down to 300. This allowed all major alarms to be covered including pressure, discharge, quantity of waste water discharged,temperature, carbon dioxide content, oxygen & sulphur content, and the water’s pH.
